[Nephrotoxicity of anti-infectious medication].
D000617:Aminoglycosides / Q000009:adverse effects / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000378:metabolism; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000378:metabolism; D004796:Clinical Enzyme Tests; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000276:immunology; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D009395:Nephritis, Interstitial / Q000139:chemically induced / Q000276:immunology; D010455:Peptides / Q000009:adverse effects / Q000378:metabolism; D012293:Rifampin / Q000009:adverse effects / Q000378:metabolism
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D010455:Peptides; D012293:Rifampin
Aspecte ale nefrotoxicităţii medicaţei antiinfecţioase.